Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

116.82 +1.85 (+1.61%)

Streaming Delayed Price Updated: 1:02 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket ↗

August 26, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Analyst Ratings for Guardant Health ↗

August 25, 2022

Within the last quarter, Guardant Health (NASDAQ:GH) has observed the following analyst ratings:

Via Benzinga

Recap: Guardant Health Q2 Earnings ↗

August 04, 2022

Guardant Health (NASDAQ:GH) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:03 PM. Here's what investors need to know about the announcement.

Via Benzinga

Guardant Health's Return On Capital Employed Insights ↗

August 23, 2022

Benzinga Pro data, Guardant Health (NASDAQ:GH) reported Q2 sales of $109.14 million. Earnings fell to a loss of $229.43 million, resulting in a 86.18% decrease from last quarter.

Via Benzinga

Guardant Health Expands Use of Guardant Reveal™ Liquid Biopsy Test for Residual Disease Detection and Recurrence Monitoring to Include Early-Stage Breast and Lung Cancers

August 15, 2022

From Guardant Health, Inc.

Via Business Wire

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 12, 2022

Via Benzinga

Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation ↗

August 12, 2022

Via Benzinga

Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for Daiichi Sankyo and AstraZeneca’s ENHERTU® for Treatment of NSCLC Patients With Activating HER2 Mutations

August 12, 2022

From Guardant Health, Inc.

Via Business Wire

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference

August 08, 2022

From Guardant Health, Inc.

Via Business Wire

Uber Dumped By Large Shareholder As Billionaire's 'Vision' Suffers Investment Struggles ↗

August 08, 2022

After reporting one of its largest losses ever, SoftBank Group Corp (OTC: SFTBY) has turned to alternative methods to regain lost capital.

Via Benzinga

Guardant Health and Blueprint Medicines present real-world data identifying EGFR C797X mutation as most common resistance mechanism to osimertinib therapy at IASLC 2022 World Conference on Lung Cancer

August 08, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces New Data from its Portfolio of Blood Tests and GuardantINFORM™ Real-World Clinical-Genomic Platform at IASLC 2022 World Conference on Lung Cancer

August 05, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Reports Second Quarter 2022 Financial Results

August 04, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Receives Medicare Coverage for Guardant Reveal™ Test

August 02, 2022

From Guardant Health, Inc.

Via Business Wire

5 Top Stocks Cathie Wood Bought This Week ↗

July 29, 2022

Despite a 50% YTD drawdown in ARKK, Cathie Wood has continued her purchases of high growth companies, such as TDOC and BILL stocks.

Via InvestorPlace

Guardant Health to Report Second Quarter 2022 Financial Results on August 4, 2022

July 13, 2022

From Guardant Health, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 12, 2022

Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 07, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Steve E. Krognes Joins Guardant Health Board of Directors

July 07, 2022

From Guardant Health, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture

June 13, 2022

From Guardant Health, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022 ↗

June 03, 2022

Via Benzinga

Guardant Health to Participate in Upcoming June Investor Conferences

May 26, 2022

From Guardant Health, Inc.

Via Business Wire

First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d’Hebron Institute of Oncology

May 25, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

May 23, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022

May 21, 2022

From Guardant Health, Inc.

Via Business Wire

90 Biggest Movers From Yesterday ↗

May 10, 2022

Gainers

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

May 09, 2022

Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.